As patients increasingly turn to artificial intelligence for information about their symptoms, clinicians are encountering a new dynamic in the consulting room. Dr Emma Green and Dr Blesset Nkambule explore the benefits and medicolegal risks of AI-assisted self-diagnosis, and wha...

Hypertension remains one of the most important modifiable cardiovascular risk factors worldwide, yet rates of diagnosis, treatment, and control remain inadequate. Contemporary management increasingly extends beyond achieving a target reading, incorporating accurate measurement, c...

Low-density lipoprotein cholesterol remains central to atherosclerotic cardiovascular disease prevention, but contemporary lipid assessment extends beyond a single measurement. New guidance incorporates lipoprotein(a), apolipoprotein B, triglyceride-rich particles, coronary arter...

Join Specialist Forum for a comprehensive overview of the new European Society of Cardiology hypertension guidelines, with discussion of implications for South African practice — thresholds, combination therapy, and when to refer.

Review the latest continuous glucose monitoring systems, insulin pump technologies, and AI-driven decision support tools for diabetes management with Specialist Forum.

An ethics-focused Specialist Forum webinar covering advance directives, palliative sedation, the distinction between killing and allowing to die, and the HPCSA ethical guidelines.

Over the past 30 years, atrial fibrillation management has shifted from a predominantly drug-centred approach towards earlier rhythm control, increasingly sophisticated catheter ablation, and more individualised treatment. Yet anti-arrhythmic drugs remain integral to contemporary...

Incretin-based therapies are reshaping the management of type 2 diabetes and obesity. Once regarded primarily as glucose-lowering medicines, glucagon-like peptide-1 receptor agonists and newer dual-agonist therapies now offer substantial weight reduction and, in selected populati...

Perhaps the greatest value of the CKM concept is not the creation of another diagnostic label. It is the change in clinical perspective it encourages. A patient with obesity, T2D, albuminuria, hypertension, and early HF does not have five unrelated problems.